| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 12/15/2005 | CA2562675A1 Delayed-setting calcium phosphate pastes |
| 12/14/2005 | EP1604677A1 Composition having antioxidant, anti-inflammatory, and immunostimulant actions |
| 12/14/2005 | EP1604672A1 Method of transdermal and transmucosal absorption of carbon dioxide and cosmetic method and therapeutic method |
| 12/14/2005 | EP1604646A1 Viscous compositions containing carbon dioxide |
| 12/14/2005 | EP1604645A1 Viscous compositions containing carbon dioxide |
| 12/14/2005 | EP1604009A2 Method for identifying risk of melanoma and treatments thereof |
| 12/14/2005 | EP1603593A2 Pharmaceutical composition |
| 12/14/2005 | EP1603578A2 Cystitis treatment with high dose chondroitin sulfate |
| 12/14/2005 | EP1603575A2 Nemorubicin as radiosensitizer in combination with radiation therapy against tumors |
| 12/14/2005 | EP1603537A2 A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained supression of gastric acid |
| 12/14/2005 | EP1603520A1 Composition comprising particulate zinc materials having a defined crystallite size |
| 12/14/2005 | EP1603499A2 Invisible patch for the controlled delivery of cosmetic, dermatological, and pharmaceutical active ingredients onto the skin |
| 12/14/2005 | EP1247526B1 Perfusion liquid preparations for ophthalmic operations |
| 12/14/2005 | EP1082103B1 Spill resistant pharmaceutical compositions |
| 12/14/2005 | CN1708310A Anticancer or antiviral composition |
| 12/14/2005 | CN1708297A Acetyl-l-carnitine for the prevention and/or treatment of peripheral neuropathies induced by anticancer agents |
| 12/14/2005 | CN1708296A Combinations of anti-cancer agents |
| 12/14/2005 | CN1708283A Skin preparations for external use |
| 12/14/2005 | CN1706378A Composition for treating inflammation which contains zinc pyrrolidonecarboxylate |
| 12/14/2005 | CN1231226C Compound formulation for treating myopia, hypermetropia, strabismus and amblyopia |
| 12/14/2005 | CA2509007A1 Agents for producing the health-benefits of repeated exercise |
| 12/11/2005 | CA2467769A1 Methods and formulations for testosterone suppression |
| 12/08/2005 | WO2005115526A2 Methods of treating abnormal biological conditions using metal oxides |
| 12/08/2005 | WO2005115472A2 Compositions comprising gamma-linolenic acid and iodine for improving breast health in women |
| 12/08/2005 | WO2005115428A2 Supplement containing carotenoid, nicotinamide, zinc, water soluble extract of uncaria species and method using the same |
| 12/08/2005 | WO2005115423A1 Using organic and/or inorganic potassium and its salts to treat autoimmune and other health disorders and methods of administering the same |
| 12/08/2005 | WO2005115417A2 Polycationic antimicrobial therapeutic |
| 12/08/2005 | WO2005115416A2 Method of treating with chlorine dioxide |
| 12/08/2005 | WO2005115415A1 Method for attenuating free radical formation resulting from a bodily insult |
| 12/08/2005 | WO2005115414A2 Orally-administrable compositions comprising stable amorphous calcium carbonate |
| 12/08/2005 | WO2005115356A2 Anti-microbial handle system |
| 12/08/2005 | WO2005115342A1 Particulate comprising a calcium-containing compound and a sugar alcohol |
| 12/08/2005 | WO2005089737A3 Materials and methods for inhibiting wip1 |
| 12/08/2005 | WO2005070461A3 Compositions of an anticonvulsant and an antipsychotic drug for affecting weight loss |
| 12/08/2005 | WO2005042142A8 Thermosensitive, biocompatible polymer carriers with a variable physical structure for treatment, diagnosis and analysis |
| 12/08/2005 | US20050272738 Combined treatment with oxaliplatin and an epidermal growth factor receptor kinase inhibitor |
| 12/08/2005 | US20050272707 Method for preventing or reducing secondary fractures after hip fracture |
| 12/08/2005 | US20050272163 Separating from excipient active hematinic species present in iron-saccharidic compositions, such as sodium ferric gluconate complex, ferric hydroxide-sucrose complex and ferric saccharate complex; analytical quantification by liquid chromatography and lasers of molecular characterisations; drugs |
| 12/08/2005 | US20050271779 Microbiological control in poultry processing |
| 12/08/2005 | US20050271749 Electrolyte purgative |
| 12/08/2005 | US20050271747 Combined treatment with cisplatin and an epidermal growth factor receptor kinase inhibitor |
| 12/08/2005 | US20050271746 Topical treatments for abnormal biological conditions and method of topically treating such conditions |
| 12/08/2005 | US20050271745 Magnetic nanoparticle compositions, and methods related thereto |
| 12/08/2005 | US20050271744 Comprising a peptide fraction which is preferably rich in di- and tripeptides in combination with an insulin sensitizer, preferably a natural or pharmaceutical insulin sensitizer; suitable as pharmaceutical or food or a food supplement; especially useful for Type 2 diabetes |
| 12/08/2005 | US20050271743 Treatment of inflammatory skin conditions |
| 12/08/2005 | US20050271742 Injectable calcium phosphate cements and the preparation and use thereof |
| 12/08/2005 | US20050271741 Quick-setting paste for use in dental and bone prostheses; particles with a size of 0.05-100 microns with surface whiskers or fine crystals with a width of 1-100 nm and a length of 1-1000 nm; aqueous hardening-promoter; paste is non-dispersive in an aqueous solution |
| 12/08/2005 | US20050271740 Repairing a defect or a cavity in a bone or a tooth by injecting a quick-setting paste with particles with a size of 0.05-100 microns with surface whiskers or fine crystals with a width of 1-100 nm and a length of 1-1000 nm; aqueous hardening-promoter; paste is non-dispersive in an aqueous solution |
| 12/08/2005 | US20050271726 Immune enhancing compositions and methods of use thereof |
| 12/08/2005 | US20050271699 Biodegradable composition with prolonged release of the biological active compound and preparation thereof |
| 12/08/2005 | US20050271648 Carbon nanotube structure and production method thereof |
| 12/08/2005 | US20050271632 Methods of modulating hair growth |
| 12/08/2005 | US20050271618 Methods of reducing aggregation of IL-1ra |
| 12/08/2005 | US20050271606 Composition for treating inflammation which contains zinc pyrrolidonecarboxylate |
| 12/08/2005 | US20050271600 Fiber supplement |
| 12/08/2005 | US20050269238 Dispenser for progestin used for acute and maintenance treatment of DUB |
| 12/08/2005 | US20050268820 Bioresorable; high speed setting cement |
| 12/08/2005 | US20050268819 High speed setting cement; bioresorbable |
| 12/08/2005 | DE102004025988A1 Verwendung von Vanadylverbindungen zur Behandlung von Tumorerkrankungen Use of vanadyl compounds for the treatment of tumor diseases |
| 12/08/2005 | DE102004023828A1 Lösung für die Peritonealdialyse Solution for peritoneal dialysis |
| 12/08/2005 | DE102004023732A1 Use of silicon containing and phosphorous-free glass for the treatment of e.g. autoimmune inflammatory diseases, infections, allergies, arthritis, dermatosis, stomach/gastric diseases and memory disorders |
| 12/08/2005 | DE102004021532A1 Dispersion mit insektizider Wirkung Dispersion having insecticidal activity |
| 12/08/2005 | CA2581703A1 Particulate comprising a calcium-containing compound and a sugar alcohol |
| 12/08/2005 | CA2567972A1 Orally-administrable compositions comprising stable amorphous calcium carbonate |
| 12/08/2005 | CA2567637A1 Using organic and/or inorganic potassium and its salts to treat autoimmune and other health disorders and methods of administering the same |
| 12/08/2005 | CA2566861A1 Methods and reagents for the treatment of immunoinflammatory disorders |
| 12/08/2005 | CA2565556A1 Polycationic antimicrobial therapeutic |
| 12/08/2005 | CA2564592A1 Compositions for improving breast health in women |
| 12/07/2005 | EP1602716A1 Selenium-enriched biomass, method of preparing thereof and probiotic and nutraceutic products including said biomass |
| 12/07/2005 | EP1601367A2 The combined use of cruciferous indoles and chelators for the treatment of papillomavirus-related conditions |
| 12/07/2005 | EP1601364A2 Method of treating and preventing hyperparathyroidism with vitamin d2 or d4 compounds |
| 12/07/2005 | EP1337228B1 Compositions for removing human cerumen |
| 12/07/2005 | EP1330164B1 Antibacterial agents and antibacterial and deodorizing solution comprising the same |
| 12/07/2005 | EP1296639B1 Use of green-light emitting materials in pharmaceutical compositions |
| 12/07/2005 | EP1151751B1 Cataplasms containing vitamin c or its derivative |
| 12/07/2005 | EP1038524B1 L-threonate ferrous, as well as pharmaceutical composition and use for improving and treating human anemia thereof |
| 12/07/2005 | EP1030567B9 System for dialysis and shock treatment |
| 12/07/2005 | EP0998886B1 Hot fomentations |
| 12/07/2005 | EP0957917B1 Vitronectin receptor antagonists |
| 12/07/2005 | EP0765163B1 Adjuvant compositions comprising a mineral salt and another immunostimulating compound |
| 12/07/2005 | CN1705682A Water-soluble iron-carbohydrate complexes, production thereof, and medicaments containing said complexes |
| 12/07/2005 | CN1705494A Colon cleansing compositions and methods |
| 12/07/2005 | CN1704121A Anti-angiogenic compositions and methods of use |
| 12/07/2005 | CN1704067A Medicine composition for ophthalmology department |
| 12/07/2005 | CN1230245C Cartridges useful in cleaning dialysis solutions |
| 12/07/2005 | CN1230199C Use of nitric oxide for treatment of airway constriction |
| 12/07/2005 | CN1230181C Bone repairing material |
| 12/07/2005 | CN1230150C Slow release pharmaceutical compositions comprising lithium carbonate |
| 12/06/2005 | US6972127 administering an effective dose of a polypeptide comprising an immunogenic fragment of A beta (SEQ ID NO:1) and an adjuvant in a regime effective to induce an immune response comprising antibodies to the A beta fragment; Alzheimer's disease |
| 12/06/2005 | CA2079831C Biodegradable polymer composition |
| 12/01/2005 | WO2005113030A1 Tissue closing preparation |
| 12/01/2005 | WO2005112958A2 Rapid setting calcium phosphate cements |
| 12/01/2005 | WO2005112957A1 Treatment of lung diseases and pre-lung disease conditions |
| 12/01/2005 | WO2005112956A1 Use of vanadyl compounds for treating tumorous diseases |
| 12/01/2005 | WO2005112955A1 A composition for prevention and treatment of colon adenomas |
| 12/01/2005 | WO2005112887A2 Composition comprising intercalated functional-active organic compounds |
| 12/01/2005 | WO2005112881A1 The dispersible montmorillonite tablet and its preparation technology |
| 12/01/2005 | WO2005112872A1 Peroxide compounds for the prevention and treatment of sexual dysfunction in humans |
| 12/01/2005 | WO2005007071A3 Skin formulation |
| 12/01/2005 | US20050267233 Anti-microbial handle system |